CRM — long thesis
Thesis
CRM is a deeply beaten-down SaaS leader (down 30%+ YTD) with a $25B buyback providing a floor. Q4 FY2026 EPS beat estimates by 25%. However, the stock is under significant pressure: Citigroup lowered PT to $188, Wells Fargo maintains Hold, extended renewal cycles are concerning, and CRM earnings are May 27 — a binary event in 2 weeks. The position is small and below cost basis. Analyst consensus PT of $279 implies substantial upside, but near-term catalysts are scarce in the current rate-shock macro. The thesis is to hold through earnings as a value/contrarian play with buyback support, but with tight risk management given the macro headwinds.
Triggers
Entry: Already held — adopted into thesis management
Exit: Hold through May 27 earnings if stock stabilizes above $160. If earnings beat and guidance is strong, hold for recovery toward $200-220 range. Exit on any earnings miss or guidance cut. Take profits above $225.
Invalidation: Stock breaks below $155 pre-earnings (would signal further fundamental deterioration). Earnings miss or guidance cut on May 27. Revenue growth decelerates below 8% YoY. Agentforce/AI monetization fails to materialize in next two quarters. CPI remains above 3.5% with no rate relief, maintaining pressure on SaaS multiples.
Cited evidence
News
- CRM Citigroup Maintains Neutral on Salesforce, Lowers Price Target to $188